Sökning: WFRF:(Löfgren Burström Anna)
> (2015-2019) >
MicroRNA expression...
-
Lundberg, IdaUmeå universitet,Patologi
(författare)
MicroRNA expression in KRAS- and BRAF-mutated colorectal cancers
- Artikel/kapitelEngelska2018
Förlag, utgivningsår, omfång ...
-
International Institute of Anticancer Research,2018
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-133409
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-133409URI
-
https://doi.org/10.21873/anticanres.12272DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Originally included in thesis in manuscript form
-
Background/Aim: KRAS and BRAF are two genes commonly mutated in colorectal cancer (CRC). Even though BRAF is a downstream target of KRAS in the MAPK signalling pathway, KRAS- and BRAF-mutated CRCs are found to display several different clinical and histopathological features. We investigated whether a differential expression of microRNAs (miRNAs) could explain the clinicopathological differences seen between KRAS-and BRAF-mutated CRCs.Materials and Methods: Using a PCR array, we analyzed the expression of 84 different miRNAs in CRC cell lines wild-type in KRAS and BRAF, or mutated in KRAS or BRAF.Results: Ten miRNAs were selected for further analyses in tumor tissue specimens (let-7a, let-7i, miR-10a, miR-10b, miR-31, miR-100, miR-181a, miR-181b, miR-372, and miR-373). BRAF-mutated tumors were found to express significantly higher levels of miR-31 as well as significantly lower levels of miR-373, compared to wild-type tumors.Conclusion: Our results suggest that KRAS and BRAF-mutated CRCs may have different miRNA signatures compared to CRC tumors wild-type in KRAS and BRAF. However, no difference in expression levels between KRAS-and BRAF-mutated tumors was evident for the miRNAs analyzed in this study.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Wikberg, Maria L.Umeå universitet,Patologi(Swepub:umu)mahe0061
(författare)
-
Ljuslinder, IngridUmeå universitet,Onkologi(Swepub:umu)inlj0001
(författare)
-
Li, XingruUmeå universitet,Patologi(Swepub:umu)xili0010
(författare)
-
Myte, RobinUmeå universitet,Onkologi(Swepub:umu)romy0001
(författare)
-
Zingmark, CarlUmeå universitet,Patologi(Swepub:umu)cazi0001
(författare)
-
Löfgren-Burström, AnnaUmeå universitet,Patologi(Swepub:umu)anlo0002
(författare)
-
Edin, SofiaUmeå universitet,Patologi(Swepub:umu)soed0001
(författare)
-
Palmqvist, RichardUmeå universitet,Patologi(Swepub:umu)ripa0001
(författare)
-
Umeå universitetPatologi
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Anticancer Research: International Institute of Anticancer Research38:2, s. 677-6830250-70051791-7530
Internetlänk
Hitta via bibliotek
Till lärosätets databas